-
Archives
- February 2020
- August 2018
- July 2018
- June 2018
- July 2017
- May 2017
- January 2017
- October 2016
- June 2016
- March 2016
- January 2016
- November 2015
- August 2015
- July 2015
- June 2015
- May 2015
- June 2014
- May 2014
- April 2014
- December 2012
- September 2012
- July 2012
- May 2012
- April 2012
- February 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
-
Meta
Monthly Archives: March 2016
Coalition Comments on PET GMP Recordkeeping Burden
On February 29, 2016, the Coalition submitted comments to the FDA on the burdens associated with the PET drug Good Manufacturing Practice (GMP) regulations at 21 CFR part 212. As previously reported, the FDA issued a Federal Notice on December … Continue reading
Posted in PET Drugs
Leave a comment
